<?xml version="1.0" encoding="UTF-8"?><section enum="866.9" typeNdiv="TITLE:8:CHAPTER:I:SUBCHAP:H:PART:866:SUBPART:A"><div8 n="ยง 866.9" node="21:8.0.1.1.20.1.1.3" type="SECTION">
                    <head>ยง 866.9   Limitations of exemptions from section 510(k) of the Federal Food, Drug, and Cosmetic Act (the act).</head>
                    <p>The exemption from the requirement of premarket notification (section 510(k) of the <linkedEntity identifier="Entity:c_715" occur="1" src="Agrovoc">act</linkedEntity>) for a generic type of class I or II device is only to the extent that the device has existing or reasonably foreseeable characteristics of commercially distributed devices within that generic type or, in the case of in vitro diagnostic devices, only to the extent that misdiagnosis as a result of using the device would not be associated with high <linkedEntity identifier="Entity:c_4936" occur="1" src="Agrovoc">morbidity</linkedEntity> or <linkedEntity identifier="Entity:c_4945" occur="1" src="Agrovoc">mortality</linkedEntity>. Accordingly, manufacturers of any commercially distributed class I or II device for which FDA has granted an exemption from the requirement of premarket notification must still submit a premarket notification to FDA before introducing or delivering for introduction into interstate <linkedEntity identifier="Entity:c_7848" occur="1" src="Agrovoc">commerce</linkedEntity> for <linkedEntity identifier="Entity:c_2338" occur="1" src="Agrovoc">commercial distribution</linkedEntity> the device when:</p>
                    <p class="psection-1"><enumxml>(a)</enumxml> The device is intended for a use different from the intended use of a legally marketed device in that generic type of device; e.g., the device is intended for a different medical purpose, or the device is intended for lay use where the former intended use was by <linkedEntity identifier="Entity:c_3511" occur="1" src="Agrovoc">health</linkedEntity> care professionals only;</p>
                    <p class="psection-1"><enumxml>(b)</enumxml> The modified device operates using a different fundamental scientific <linkedEntity identifier="Entity:c_7644" occur="1" src="Agrovoc">technology</linkedEntity> than a legally marketed device in that generic type of device; e.g., a surgical instrument cuts tissue with a laser beam rather than with a sharpened metal blade, or an in vitro diagnostic device detects or identifies infectious <linkedEntity identifier="Entity:c_49873" occur="1" src="Agrovoc">agents</linkedEntity> by using deoxyribonucleic acid (<linkedEntity identifier="Entity:c_2347" occur="1" src="Agrovoc">DNA</linkedEntity>) probe or nucleic acid <linkedEntity identifier="Entity:c_3706" occur="1" src="Agrovoc">hybridization</linkedEntity> <linkedEntity identifier="Entity:c_7644" occur="1" src="Agrovoc">technology</linkedEntity> rather than culture or <linkedEntity identifier="Entity:c_3807" occur="1" src="Agrovoc">immunoassay</linkedEntity> <linkedEntity identifier="Entity:c_7644" occur="1" src="Agrovoc">technology</linkedEntity>; or</p>
                    <p class="psection-1"><enumxml>(c)</enumxml> The device is an in vitro device that is intended:</p>
                    <p class="psection-2"><enumxml>(1)</enumxml> For use in the <linkedEntity identifier="Entity:c_2238" occur="1" src="Agrovoc">diagnosis</linkedEntity>, monitoring, or screening of neoplastic diseases with the exception of immunohistochemical devices;</p>
                    <p class="psection-2"><enumxml>(2)</enumxml> For use in screening or <linkedEntity identifier="Entity:c_2238" occur="2" src="Agrovoc">diagnosis</linkedEntity> of familial or acquired genetic <linkedEntity identifier="Entity:c_15584" occur="1" src="Agrovoc">disorders</linkedEntity>, including inborn errors of <linkedEntity identifier="Entity:c_4769" occur="1" src="Agrovoc">metabolism</linkedEntity>;</p>
                    <p class="psection-2"><enumxml>(3)</enumxml> For measuring an analyte that serves as a surrogate marker for screening, <linkedEntity identifier="Entity:c_2238" occur="3" src="Agrovoc">diagnosis</linkedEntity>, or monitoring life-threatening diseases such as acquired immune deficiency syndrome (<linkedEntity identifier="Entity:c_37845" occur="1" src="Agrovoc">AIDS</linkedEntity>), chronic or active <linkedEntity identifier="Entity:c_11527" occur="1" src="Agrovoc">hepatitis</linkedEntity>, <linkedEntity identifier="Entity:c_7997" occur="1" src="Agrovoc">tuberculosis</linkedEntity>, or myocardial <linkedEntity identifier="Entity:c_8160" occur="1" src="Agrovoc">infarction</linkedEntity> or to monitor <linkedEntity identifier="Entity:c_7715" occur="1" src="Agrovoc">therapy</linkedEntity>;</p>
                    <p class="psection-2"><enumxml>(4)</enumxml> For assessing the <linkedEntity identifier="Entity:c_6612" occur="1" src="Agrovoc">risk</linkedEntity> of <linkedEntity identifier="Entity:c_34231" occur="1" src="Agrovoc">cardiovascular diseases</linkedEntity>;</p>
                    <p class="psection-2"><enumxml>(5)</enumxml> For use in <linkedEntity identifier="Entity:c_10361" occur="1" src="Agrovoc">diabetes</linkedEntity> <linkedEntity identifier="Entity:c_16086" occur="1" src="Agrovoc">management</linkedEntity>;</p>
                    <p class="psection-2"><enumxml>(6)</enumxml> For identifying or inferring the identity of a microorganism directly from clinical material;</p>
                    <p class="psection-2"><enumxml>(7)</enumxml> For detection of <linkedEntity identifier="Entity:c_493" occur="1" src="Agrovoc">antibodies</linkedEntity> to <linkedEntity identifier="Entity:c_4807" occur="1" src="Agrovoc">microorganisms</linkedEntity> other than immunoglobulin G (IgG) or IgG assays when the results are not qualitative, or are used to determine <linkedEntity identifier="Entity:c_3802" occur="1" src="Agrovoc">immunity</linkedEntity>, or the assay is intended for use in matrices other than serum or plasma;</p>
                    <p class="psection-2"><enumxml>(8)</enumxml> For noninvasive <linkedEntity identifier="Entity:c_7683" occur="1" src="Agrovoc">testing</linkedEntity> as defined in ยง 812.3(k) of this chapter; and</p>
                    <p class="psection-2"><enumxml>(9)</enumxml> For near patient <linkedEntity identifier="Entity:c_7683" occur="2" src="Agrovoc">testing</linkedEntity> (point of care).</p>
                    <cita type="N">[<aref type="FR"><subref page="2311" target="http://frwebgate.access.gpo.gov/cgi-bin/getpage.cgi?dbname={2000}_register&amp;position=all&amp;page=2311" title="65" type="full">65 FR 2311</subref></aref>, Jan. 14, 2000]
</cita>
                  </div8>
                <origin breadcrumb="Title 21:Chapter I:Subchapter H:Part 866:Subpart A" generations="5"><gen n="4">Title 21 - Food and Drugs--Volume 8</gen><gen n="3"> CHAPTER I - Food and Drug Administration, Department of Health and Human Services (Continued)</gen><gen n="2">SUBCHAPTER H - Medical Devices 
</gen><gen n="1">PART 866 - Immunology and Microbiology Devices</gen><gen n="0">Subpart A - General Provisions</gen></origin></section>